Osaka, Japan

Yasuko Adachi

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuko Adachi. Retrieved from https://idiyas.com/inventor/yasuko-adachi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuko Adachi: Innovator in Antitumor Agents

Introduction

Yasuko Adachi is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of chemistry, particularly in the development of antitumor agents. Her innovative work has led to the creation of a unique compound that holds promise in cancer treatment.

Latest Patents

Yasuko Adachi holds a patent for "Ammine-alicyclic amine-platinum complexes and antitumor agents." This patent describes a compound of the formula (I), which includes various functional groups that enhance its efficacy as an antitumor agent. The compound is characterized by its potential to combat cancer, making it a valuable addition to the pharmaceutical industry.

Career Highlights

Throughout her career, Yasuko Adachi has been associated with Shionogi Company Limited, where she has contributed to groundbreaking research and development. Her work has not only advanced scientific knowledge but has also paved the way for new therapeutic options in oncology.

Collaborations

Yasuko Adachi has collaborated with notable colleagues, including Tetsushi Totani and Katsutoshi Aono. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yasuko Adachi's contributions to the field of antitumor agents exemplify her dedication to advancing medical science. Her innovative spirit and collaborative efforts continue to inspire future research in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…